
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Elizabeth T. Cirulli, Brittany N. Lasseigne, Slavé Petrovski, et al.
Science (2015) Vol. 347, Iss. 6229, pp. 1436-1441
Open Access | Times Cited: 912
Elizabeth T. Cirulli, Brittany N. Lasseigne, Slavé Petrovski, et al.
Science (2015) Vol. 347, Iss. 6229, pp. 1436-1441
Open Access | Times Cited: 912
Showing 26-50 of 912 citing articles:
C9orf72 is required for proper macrophage and microglial function in mice
Jacqueline G. O’Rourke, Laurent Bogdanik, Alberto Yáñez, et al.
Science (2016) Vol. 351, Iss. 6279, pp. 1324-1329
Open Access | Times Cited: 505
Jacqueline G. O’Rourke, Laurent Bogdanik, Alberto Yáñez, et al.
Science (2016) Vol. 351, Iss. 6279, pp. 1324-1329
Open Access | Times Cited: 505
Converging pathways in neurodegeneration, from genetics to mechanisms
Li Gan, Mark Cookson, Leonard Petrucelli, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1300-1309
Open Access | Times Cited: 415
Li Gan, Mark Cookson, Leonard Petrucelli, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1300-1309
Open Access | Times Cited: 415
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A. A. van der Spek, Mark K. Bakker, et al.
Nature Genetics (2021) Vol. 53, Iss. 12, pp. 1636-1648
Open Access | Times Cited: 388
Wouter van Rheenen, Rick A. A. van der Spek, Mark K. Bakker, et al.
Nature Genetics (2021) Vol. 53, Iss. 12, pp. 1636-1648
Open Access | Times Cited: 388
RNA-binding proteins with prion-like domains in health and disease
Alice Ford Harrison, James Shorter
Biochemical Journal (2017) Vol. 474, Iss. 8, pp. 1417-1438
Open Access | Times Cited: 384
Alice Ford Harrison, James Shorter
Biochemical Journal (2017) Vol. 474, Iss. 8, pp. 1417-1438
Open Access | Times Cited: 384
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Daichao Xu, Taijie Jin, Hong Zhu, et al.
Cell (2018) Vol. 174, Iss. 6, pp. 1477-1491.e19
Open Access | Times Cited: 382
Daichao Xu, Taijie Jin, Hong Zhu, et al.
Cell (2018) Vol. 174, Iss. 6, pp. 1477-1491.e19
Open Access | Times Cited: 382
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Quanli Wang, Ryan S. Dhindsa, Keren Carss, et al.
Nature (2021) Vol. 597, Iss. 7877, pp. 527-532
Open Access | Times Cited: 379
Quanli Wang, Ryan S. Dhindsa, Keren Carss, et al.
Nature (2021) Vol. 597, Iss. 7877, pp. 527-532
Open Access | Times Cited: 379
Loss of C9 ORF 72 impairs autophagy and synergizes with polyQ Ataxin‐2 to induce motor neuron dysfunction and cell death
Chantal Sellier, Maria‐Letizia Campanari, Camille Corbier, et al.
The EMBO Journal (2016) Vol. 35, Iss. 12, pp. 1276-1297
Open Access | Times Cited: 366
Chantal Sellier, Maria‐Letizia Campanari, Camille Corbier, et al.
The EMBO Journal (2016) Vol. 35, Iss. 12, pp. 1276-1297
Open Access | Times Cited: 366
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 348
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 348
Genetics of glaucoma
Janey L. Wiggs, Louis R. Pasquale
Human Molecular Genetics (2017) Vol. 26, Iss. R1, pp. R21-R27
Open Access | Times Cited: 341
Janey L. Wiggs, Louis R. Pasquale
Human Molecular Genetics (2017) Vol. 26, Iss. R1, pp. R21-R27
Open Access | Times Cited: 341
Targeting RIPK1 for the treatment of human diseases
Alexei Degterev, Dimitry Ofengeim, Junying Yuan
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 9714-9722
Open Access | Times Cited: 332
Alexei Degterev, Dimitry Ofengeim, Junying Yuan
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 9714-9722
Open Access | Times Cited: 332
Selective autophagy as a potential therapeutic target for neurodegenerative disorders
Aurora Scrivo, Mathieu Bourdenx, Olatz Pampliega, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 9, pp. 802-815
Open Access | Times Cited: 322
Aurora Scrivo, Mathieu Bourdenx, Olatz Pampliega, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 9, pp. 802-815
Open Access | Times Cited: 322
Necroptosis in development and diseases
Bing Shan, Heling Pan, Ayaz Najafov, et al.
Genes & Development (2018) Vol. 32, Iss. 5-6, pp. 327-340
Open Access | Times Cited: 319
Bing Shan, Heling Pan, Ayaz Najafov, et al.
Genes & Development (2018) Vol. 32, Iss. 5-6, pp. 327-340
Open Access | Times Cited: 319
Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy
Andrew S. Moore, Erika L.F. Holzbaur
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 24
Open Access | Times Cited: 308
Andrew S. Moore, Erika L.F. Holzbaur
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 24
Open Access | Times Cited: 308
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Garam Kım, Olivia Gautier, Eduardo Tassoni-Tsuchida, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 822-842
Open Access | Times Cited: 301
Garam Kım, Olivia Gautier, Eduardo Tassoni-Tsuchida, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 822-842
Open Access | Times Cited: 301
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers, Stanley H. Appel
The Lancet Neurology (2019) Vol. 18, Iss. 2, pp. 211-220
Closed Access | Times Cited: 292
David R. Beers, Stanley H. Appel
The Lancet Neurology (2019) Vol. 18, Iss. 2, pp. 211-220
Closed Access | Times Cited: 292
Amyotrophic Lateral Sclerosis: An Update for 2018
Björn Oskarsson, Tania F. Gendron, Nathan P. Staff
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 11, pp. 1617-1628
Open Access | Times Cited: 291
Björn Oskarsson, Tania F. Gendron, Nathan P. Staff
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 11, pp. 1617-1628
Open Access | Times Cited: 291
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Cyril Pottier, Kevin F. Bieniek, Ni Cole A. Finch, et al.
Acta Neuropathologica (2015) Vol. 130, Iss. 1, pp. 77-92
Open Access | Times Cited: 288
Cyril Pottier, Kevin F. Bieniek, Ni Cole A. Finch, et al.
Acta Neuropathologica (2015) Vol. 130, Iss. 1, pp. 77-92
Open Access | Times Cited: 288
Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond
Baris Bingol, Morgan Sheng
Free Radical Biology and Medicine (2016) Vol. 100, pp. 210-222
Closed Access | Times Cited: 283
Baris Bingol, Morgan Sheng
Free Radical Biology and Medicine (2016) Vol. 100, pp. 210-222
Closed Access | Times Cited: 283
Are aberrant phase transitions a driver of cellular aging?
Simon Alberti, Anthony A. Hyman
BioEssays (2016) Vol. 38, Iss. 10, pp. 959-968
Open Access | Times Cited: 283
Simon Alberti, Anthony A. Hyman
BioEssays (2016) Vol. 38, Iss. 10, pp. 959-968
Open Access | Times Cited: 283
Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
Ammar Al‐Chalabi, Leonard H. van den Berg, Jan H. Veldink
Nature Reviews Neurology (2016) Vol. 13, Iss. 2, pp. 96-104
Open Access | Times Cited: 274
Ammar Al‐Chalabi, Leonard H. van den Berg, Jan H. Veldink
Nature Reviews Neurology (2016) Vol. 13, Iss. 2, pp. 96-104
Open Access | Times Cited: 274
ALS Genes in the Genomic Era and their Implications for FTD
Hung Phuoc Nguyen, Christine Van Broeckhoven, Julie van der Zee
Trends in Genetics (2018) Vol. 34, Iss. 6, pp. 404-423
Open Access | Times Cited: 271
Hung Phuoc Nguyen, Christine Van Broeckhoven, Julie van der Zee
Trends in Genetics (2018) Vol. 34, Iss. 6, pp. 404-423
Open Access | Times Cited: 271
TBK1: a new player in ALS linking autophagy and neuroinflammation
James Oakes, Maria C. Davies, Mark O. Collins
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 270
James Oakes, Maria C. Davies, Mark O. Collins
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 270
Autophagy in Neurons
Andrea KH Stavoe, Erika L.F. Holzbaur
Annual Review of Cell and Developmental Biology (2019) Vol. 35, Iss. 1, pp. 477-500
Open Access | Times Cited: 267
Andrea KH Stavoe, Erika L.F. Holzbaur
Annual Review of Cell and Developmental Biology (2019) Vol. 35, Iss. 1, pp. 477-500
Open Access | Times Cited: 267
Roles of Caspases in Necrotic Cell Death
Junying Yuan, Ayaz Najafov, Bénédicte F. Py
Cell (2016) Vol. 167, Iss. 7, pp. 1693-1704
Open Access | Times Cited: 262
Junying Yuan, Ayaz Najafov, Bénédicte F. Py
Cell (2016) Vol. 167, Iss. 7, pp. 1693-1704
Open Access | Times Cited: 262
Inflammation in ALS/FTD pathogenesis
Madelyn E. McCauley, Robert H. Baloh
Acta Neuropathologica (2018) Vol. 137, Iss. 5, pp. 715-730
Open Access | Times Cited: 259
Madelyn E. McCauley, Robert H. Baloh
Acta Neuropathologica (2018) Vol. 137, Iss. 5, pp. 715-730
Open Access | Times Cited: 259